The assessment tool determines the concentration of all cholesterol types within the bloodstream, excluding high-density lipoprotein cholesterol. This calculation is derived by subtracting the high-density lipoprotein value from the total cholesterol value obtained through a standard lipid panel. As an illustration, if an individual’s total cholesterol is 200 mg/dL and their high-density lipoprotein cholesterol is 50 mg/dL, the resulting value would be 150 mg/dL.
This value serves as a significant indicator of cardiovascular risk. Its utility lies in encompassing various atherogenic lipoproteins, providing a more complete picture than low-density lipoprotein cholesterol alone. Monitoring these levels assists healthcare professionals in assessing an individual’s likelihood of developing heart disease and guides therapeutic interventions. Historically, emphasis was primarily placed on low-density lipoprotein cholesterol; however, recognizing the contribution of other cholesterol-carrying particles has led to the increased adoption of this more comprehensive metric.
